Isoflurane Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : January 2020 Pages : 180 Category: Chemicals & Nanomaterials Report Code : CM018800
Isoflurane Market by Type (Human Series, Animal Series) Application (Hospitals, Other Medical Institutions) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The isoflurane market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Isoflurane is a colorless, clear, stable fluid containing no added substances or compound stabilizers. Isoflurane has a somewhat sharp, musty, ethereal odor. Isoflurane in one ordinary sodium methoxide-methanol solution, a solid base, for more than a half year, consumed basically no antacid, demonstrative of solid base stability. Isoflurane doesn't break down within the sight of soda lime (at typical working temperatures) and doesn't assault aluminum, tin, metal, iron, or copper. Isoflurane might be utilized for enlistment and support of general anesthesia.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global isoflurane market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Piramal Critical CarePiramal Group
- Rewine Pharmaceutical
- Pfizer
- Halocarbon
- Medicon Lifesciences
- Shandong Keyuan Pharmaceutical Co., Ltd.
- AesicaConsort Medical Group
- Indofine Chemical Company, Inc.
- Lunan Pharmaceutical Group
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Isoflurane Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Human Series
o Animal Series
· Isoflurane Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Hospitals
o Other Medical Institutions
· Isoflurane Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Piramal Critical CarePiramal Group
o Rewine Pharmaceutical
o Pfizer
o Halocarbon
o Medicon Lifesciences
o Shandong Keyuan Pharmaceutical Co., Ltd.
o AesicaConsort Medical Group
o Indofine Chemical Company, Inc.
o Lunan Pharmaceutical Group
· Isoflurane Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Isoflurane Market, By Country
o U.S. Isoflurane Market
o Canada Isoflurane Market
o Mexico Isoflurane Market
o Europe
§ Europe Isoflurane Market, By Country
o Germany Isoflurane Market
o UK Isoflurane Market
o France Isoflurane Market
o Russia Isoflurane Market
o Italy Isoflurane Market
o Rest of Europe Isoflurane Market
o Asia-Pacific
§ Asia-Pacific Isoflurane Market, By Country
o China Isoflurane Market
o Japan Isoflurane Market
o South Korea Isoflurane Market
o India Isoflurane Market
o Southeast Asia Isoflurane Market
o Rest of Asia-Pacific Isoflurane Market
o South America
§ South America Isoflurane Market
o Brazil Isoflurane Market
o Argentina Isoflurane Market
o Columbia Isoflurane Market
o Rest of South America Isoflurane Market
o Middle East and Africa
§ Middle East and Africa Isoflurane Market
o Saudi Arabia Isoflurane Market
o UAE Isoflurane Market
o Egypt Isoflurane Market
o Nigeria Isoflurane Market
o South Africa Isoflurane Market
o Rest of MEA Isoflurane Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Isoflurane Market, By Type
5.1. Introduction
5.2. Global Isoflurane Revenue and Market Share by Type (2017-2027)
5.2.1. Global Isoflurane Revenue and Revenue Share by Type (2017-2027)
5.3. Human Series
5.3.1. Global Human Series Revenue and Growth Rate (2017-2027)
5.4. Animal Series
5.4.1. Global Animal Series Revenue and Growth Rate (2017-2027)
6. Isoflurane Market, By Application
6.1. Introduction
6.2. Global Isoflurane Revenue and Market Share by Application (2017-2027)
6.2.1. Global Isoflurane Revenue and Revenue Share by Application (2017-2027)
6.3. Hospitals
6.3.1. Global Hospitals Revenue and Growth Rate (2017-2027)
6.4. Other Medical Institutions
6.4.1. Global Other Medical Institutions Revenue and Growth Rate (2017-2027)
7. Isoflurane Market, By Region
7.1. Introduction
7.2. Global Isoflurane Revenue and Market Share by Regions
7.2.1. Global Isoflurane Revenue by Regions (2017-2027)
7.3. North America Isoflurane by Countries
7.3.1. North America Isoflurane Revenue and Growth Rate (2017-2027)
7.3.2. North America Isoflurane Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Isoflurane by Countries
7.4.1. Europe Isoflurane Revenue and Growth Rate (2017-2027)
7.4.2. Europe Isoflurane Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Isoflurane by Countries
7.5.1. Asia-Pacific Isoflurane Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Isoflurane Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Isoflurane by Countries
7.6.1. South America Isoflurane Revenue and Growth Rate (2017-2027)
7.6.2. South America Isoflurane Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Isoflurane by Countries
7.7.1. Middle East and Africa Isoflurane Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Isoflurane Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Piramal Critical CarePiramal Group
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Rewine Pharmaceutical
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Pfizer
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Halocarbon
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Medicon Lifesciences
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Shandong Keyuan Pharmaceutical Co., Ltd.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. AesicaConsort Medical Group
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Indofine Chemical Company, Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Lunan Pharmaceutical Group
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Isoflurane Market Forecast (2017-2027)
9.1. Global Isoflurane Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Isoflurane Market Forecast by Regions (2017-2027)
9.2.1. North America Isoflurane Market Forecast (2017-2027)
9.2.1.1. United States Isoflurane Market Forecast (2017-2027)
9.2.1.2. Canada Isoflurane Market Forecast (2017-2027)
9.2.1.3. Mexico Isoflurane Market Forecast (2017-2027)
9.2.2. Europe Isoflurane Market Forecast (2017-2027)
9.2.2.1. Germany Isoflurane Market Forecast (2017-2027)
9.2.2.2. France Isoflurane Market Forecast (2017-2027)
9.2.2.3. UK Isoflurane Market Forecast (2017-2027)
9.2.2.4. Russia Isoflurane Market Forecast (2017-2027)
9.2.2.5. Italy Isoflurane Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Isoflurane Market Forecast (2017-2027)
9.2.3. Asia-Pacific Isoflurane Market Forecast (2017-2027)
9.2.3.1. China Isoflurane Market Forecast (2017-2027)
9.2.3.2. Japan Isoflurane Market Forecast (2017-2027)
9.2.3.3. Korea Isoflurane Market Forecast (2017-2027)
9.2.3.4. India Isoflurane Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Isoflurane Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Isoflurane Market Forecast (2017-2027)
9.2.4. South America Isoflurane Market Forecast (2017-2027)
9.2.4.1. Brazil Isoflurane Market Forecast (2017-2027)
9.2.4.2. Argentina Isoflurane Market Forecast (2017-2027)
9.2.4.3. Columbia Isoflurane Market Forecast (2017-2027)
9.2.4.4. Rest of South America Isoflurane Market Forecast (2017-2027)
9.2.5. Middle East and Africa Isoflurane Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Isoflurane Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Isoflurane Market Forecast (2017-2027)
9.2.5.3. Egypt Isoflurane Market Forecast (2017-2027)
9.2.5.4. Nigeria Isoflurane Market Forecast (2017-2027)
9.2.5.5. South Africa Isoflurane Market Forecast (2017-2027)
9.2.5.6. Turkey Isoflurane Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Isoflurane Market Forecast (2017-2027)
9.3. Isoflurane Market Forecast by Type (2017-2027)
9.3.1. Isoflurane Forecast by Type (2017-2027)
9.3.2. Isoflurane Market Share Forecast by Type (2017-2027)
9.4. Isoflurane Market Forecast by Application (2017-2027)
9.4.1. Isoflurane Forecast by Application (2017-2027)
9.4.2. Isoflurane Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Isoflurane Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Isoflurane Revenue and Revenue Share by Type (2017-2018)
Figure Global Human Series Revenue and Growth Rate (2017-2018)
Figure Global Animal Series Revenue and Growth Rate (2017-2018)
Table Global Isoflurane Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Other Medical Institutions Revenue and Growth Rate (2017-2018)
Table Global Isoflurane Revenue by Regions (2017-2018)
Figure North America Isoflurane Growth Rate (2017-2018)
Figure North America Isoflurane Revenue and Growth Rate (2017-2018)
Figure North America Isoflurane by Countries (2017-2018)
Figure North America Isoflurane Revenue (Million USD) by Countries (2017-2018)
Figure United States Isoflurane Growth Rate (2017-2018)
Figure United States Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Isoflurane Growth Rate (2017-2018)
Figure Canada Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Isoflurane Growth Rate (2017-2018)
Figure Mexico Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Isoflurane Growth Rate (2017-2018)
Figure Europe Isoflurane Revenue and Growth Rate (2017-2018)
Figure Europe Isoflurane by Countries (2017-2018)
Figure Europe Isoflurane Revenue (Million USD) by Countries (2017-2018)
Figure Germany Isoflurane Growth Rate (2017-2018)
Figure Germany Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Isoflurane Growth Rate (2017-2018)
Figure France Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Isoflurane Growth Rate (2017-2018)
Figure UK Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Isoflurane Growth Rate (2017-2018)
Figure Russia Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Isoflurane Growth Rate (2017-2018)
Figure Italy Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Isoflurane Growth Rate (2017-2018)
Figure Rest of Europe Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Isoflurane Growth Rate (2017-2018)
Figure Asia-Pacific Isoflurane Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Isoflurane by Countries (2017-2018)
Figure Asia-Pacific Isoflurane Revenue (Million USD) by Countries (2017-2018)
Figure China Isoflurane Growth Rate (2017-2018)
Figure China Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Isoflurane Growth Rate (2017-2018)
Figure Japan Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Isoflurane Growth Rate (2017-2018)
Figure Korea Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Isoflurane Growth Rate (2017-2018)
Figure India Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Isoflurane Growth Rate (2017-2018)
Figure Southeast Asia Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Isoflurane Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Isoflurane Growth Rate (2017-2018)
Figure South America Isoflurane Revenue and Growth Rate (2017-2018)
Figure South America Isoflurane by Countries (2017-2018)
Figure South America Isoflurane Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Isoflurane Growth Rate (2017-2018)
Figure Brazil Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Isoflurane Growth Rate (2017-2018)
Figure Argentina Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Isoflurane Growth Rate (2017-2018)
Figure Columbia Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Isoflurane Growth Rate (2017-2018)
Figure Rest of South America Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Isoflurane Growth Rate (2017-2018)
Figure Middle East and Africa Isoflurane Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Isoflurane by Countries (2017-2018)
Figure Middle East and Africa Isoflurane Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Isoflurane Growth Rate (2017-2018)
Figure Saudi Arabia Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Isoflurane Growth Rate (2017-2018)
Figure United Arab Emirates Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Isoflurane Growth Rate (2017-2018)
Figure Egypt Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Isoflurane Growth Rate (2017-2018)
Figure Nigeria Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Isoflurane Growth Rate (2017-2018)
Figure South Africa Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Isoflurane Growth Rate (2017-2018)
Figure Turkey Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Isoflurane Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Isoflurane Revenue (Millions USD) and Growth Rate (2017-2018)
Table Piramal Critical CarePiramal Group Isoflurane Financial Overview
Table Rewine Pharmaceutical Isoflurane Financial Overview
Table Pfizer Isoflurane Financial Overview
Table Halocarbon Isoflurane Financial Overview
Table Medicon Lifesciences Isoflurane Financial Overview
Table Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Financial Overview
Table AesicaConsort Medical Group Isoflurane Financial Overview
Table Indofine Chemical Company, Inc. Isoflurane Financial Overview
Table Lunan Pharmaceutical Group Isoflurane Financial Overview
Figure Global Isoflurane Revenue (Millions USD) and Growth Rate (2018-2025)
Table Isoflurane Market Forecast by Regions (2018-2025)
Figure North America Isoflurane Market Forecast (2018-2025)
Figure United States Isoflurane Market Forecast (2018-2025)
Figure Canada Isoflurane Market Forecast (2018-2025)
Figure Mexico Isoflurane Market Forecast (2018-2025)
Figure Europe Isoflurane Market Forecast (2018-2025)
Figure Germany Isoflurane Market Forecast (2018-2025)
Figure France Isoflurane Market Forecast (2018-2025)
Figure UK Isoflurane Market Forecast (2018-2025)
Figure Russia Isoflurane Market Forecast (2018-2025)
Figure Italy Isoflurane Market Forecast (2018-2025)
Figure Rest of Europe Isoflurane Market Forecast (2018-2025)
Figure Asia-Pacific Isoflurane Market Forecast (2018-2025)
Figure China Isoflurane Market Forecast (2018-2025)
Figure Japan Isoflurane Market Forecast (2018-2025)
Figure Korea Isoflurane Market Forecast (2018-2025)
Figure India Isoflurane Market Forecast (2018-2025)
Figure Southeast Asia Isoflurane Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Isoflurane Market Forecast (2018-2025)
Figure South America Isoflurane Market Forecast (2018-2025)
Figure Brazil Isoflurane Market Forecast (2018-2025)
Figure Argentina Isoflurane Market Forecast (2018-2025)
Figure Columbia Isoflurane Market Forecast (2018-2025)
Figure Rest of South America Isoflurane Market Forecast (2018-2025)
Figure Middle East and Africa Isoflurane Market Forecast (2018-2025)
Figure Saudi Arabia Isoflurane Market Forecast (2018-2025)
Figure United Arab Emirates Isoflurane Market Forecast (2018-2025)
Figure Egypt Isoflurane Market Forecast (2018-2025)
Figure Nigeria Isoflurane Market Forecast (2018-2025)
Figure South Africa Isoflurane Market Forecast (2018-2025)
Figure Turkey Isoflurane Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Isoflurane Market Forecast (2018-2025)
Figure Global Isoflurane Forecast by Type (2018-2025)
Figure Global Isoflurane Market Share Forecast by Type (2018-2025)
Figure Global Isoflurane Forecast by Type (2018-2025)
Figure Global Isoflurane Forecast by Application (2018-2025)
Figure Global Isoflurane Market Share Forecast by Application (2018-2025)
Figure Global Isoflurane Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|